Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes

JAMA Intern Med. 2023 Jun 1;183(6):624. doi: 10.1001/jamainternmed.2023.0554.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Hepacivirus / genetics
  • Hepatitis C* / drug therapy
  • Hepatitis C, Chronic* / drug therapy
  • Humans
  • Selection Bias

Substances

  • Antiviral Agents